143. Deputy Michael Lowry asked the Minister for Health the position regarding anti-calcitonin gene-related peptide medication for the preventative treatment of chronic migraine; if the National Centre for Pharmacoeconomics has completed its full health technology assessment on the medication erenumab; when erenumab and fremanezumab will be made available to chronic migraine patients; and if he will make a statement on the matter. [45684/19]

Summary

143. Deputy Michael Lowry asked the Minister for Health the position regarding anti-calcitonin gene-related peptide medication for the preventative treatment of chronic migraine; if the National Centre for Pharmacoeconomics has completed its full health technology assessment on the medication erenumab; when erenumab and fremanezumab will be made available to chronic migraine patients; and if he will make a statement on the matter. [45684/19]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Availability

  xml · EN · 6 November 2019

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.